Concepedia

Author

Kimo Bachiashvili

The University of Texas MD Anderson Cancer Center

Also Known As

Kimo Bachiashvili

59

Publications

407

Citations

9

H-Index

13

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of Alabama at BirminghamMassachusetts General HospitalUniversity Hospitals Seidman Cancer CenterSeattle Cancer Care Alliance
KB

About

Kimo Bachiashvili is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, hematology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

198

2

Pathology

3

3

149

3

Health Sciences

1

1

49

4

Immunology

1

1

49

5

Medical Laboratory Science

1

1

124

Kimo Bachiashvili

×

6

Publications

295

Citations

6

H-Index

YearCitations

NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020

Pamela S. Becker, Elizabeth A. Griffiths, Laura Alwan,

Journal of the National Comprehensive Cancer Network

2020

124

NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022

Elizabeth A. Griffiths, Vivek Roy, Laura Alwan,

Journal of the National Comprehensive Cancer Network

2022

71

Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic

Elizabeth A. Griffiths, Laura Alwan, Kimo Bachiashvili,

Journal of the National Comprehensive Cancer Network

2021

49

Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms

Justin M. Watts, Mark D. Minden, Kimo Bachiashvili,

Therapeutic Advances in Hematology

2024

26

Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia

Sankalp Arora, Carl Zainaldin, Srilakshmi Bathini,

Leukemia Research

2022

14

Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents

Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini,

Leukemia & lymphoma/Leukemia and lymphoma

2022

11

Page 1